Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 2 |
2020 | 4 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes.
Breast Cancer Res. 2019 Aug 7;21(1):90. doi: 10.1186/s13058-019-1176-2.
Breast Cancer Res. 2019.
PMID: 31391067
Free PMC article.
Hierarchical clustering of PI3K and MAPK pathway proteins in breast cancer intrinsic subtypes.
Kruger DT, Opdam M, Sanders J, van der Noort V, Boven E, Linn SC.
Kruger DT, et al.
APMIS. 2020 Apr;128(4):298-307. doi: 10.1111/apm.13026. Epub 2020 Feb 27.
APMIS. 2020.
PMID: 31976581
Free PMC article.
Item in Clipboard
Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature.
Opdam M, van der Noort V, Kleijn M, Glas A, Mandjes I, Kleiterp S, Hilbers FS, Kruger DT, Bins AD, de Jong PC, Schiphorst PPJBM, van Dalen T, Flameling B, Rietbroek RC, Beeker A, van den Heiligenberg SM, Bakker SD, Wymenga ANM, Oving IM, Bijlsma RM, van Diest PJ, Vermorken JB, van Tinteren H, Linn SC.
Opdam M, et al. Among authors: kruger dt.
Breast Cancer Res Treat. 2022 Jul;194(2):265-278. doi: 10.1007/s10549-022-06618-z. Epub 2022 May 19.
Breast Cancer Res Treat. 2022.
PMID: 35587322
Free PMC article.
Clinical Trial.
Item in Clipboard
PI3K pathway protein analyses in metastatic breast cancer patients receiving standard everolimus and exemestane.
Kruger DT, Opdam M, van der Noort V, Sanders J, Nieuwenhuis M, de Valk B, Beelen KJ, Linn SC, Boven E.
Kruger DT, et al.
J Cancer Res Clin Oncol. 2020 Nov;146(11):3013-3023. doi: 10.1007/s00432-020-03291-x. Epub 2020 Jun 21.
J Cancer Res Clin Oncol. 2020.
PMID: 32566979
Free PMC article.
Clinical Trial.
Item in Clipboard
IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer.
Kruger DT, Alexi X, Opdam M, Schuurman K, Voorwerk L, Sanders J, van der Noort V, Boven E, Zwart W, Linn SC.
Kruger DT, et al.
Int J Cancer. 2020 Apr 15;146(8):2348-2359. doi: 10.1002/ijc.32668. Epub 2019 Oct 6.
Int J Cancer. 2020.
PMID: 31490549
Free PMC article.
Item in Clipboard
High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2- postmenopausal breast cancer patients treated with everolimus and exemestane.
Kruger DT, Jansen MPHM, Konings IRHM, Dercksen WM, Jager A, Oulad Hadj J, Sleijfer S, Martens JWM, Boven E.
Kruger DT, et al.
Mol Oncol. 2020 Mar;14(3):490-503. doi: 10.1002/1878-0261.12617. Epub 2020 Feb 7.
Mol Oncol. 2020.
PMID: 31841262
Free PMC article.
Item in Clipboard
Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences.
Kruger DT, Beelen KJ, Opdam M, Sanders J, van der Noort V, Boven E, Linn SC.
Kruger DT, et al.
Br J Cancer. 2018 Oct;119(7):832-839. doi: 10.1038/s41416-018-0221-8. Epub 2018 Oct 5.
Br J Cancer. 2018.
PMID: 30287915
Free PMC article.
Item in Clipboard
Cite
Cite